CVS Health goes in­to the biosim­i­lar mar­ket with new sub­sidiary

CVS Health an­nounced Wednes­day that it launched a busi­ness that will work with drug­mak­ers to com­mer­cial­ize and man­u­fac­ture biosim­i­lars in the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.